Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies-Reference-Cited by-同舟云学术

Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies

Published:2014-08-08 Issue: Volume:4 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Langabeer Stephen E.,Haslam Karl,Conneally Eibhlin

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference18 articles.

1. Therapy with JAK2 inhibitors for myeloproliferative neoplasms;Santos;Hematol Oncol Clin North Am,2012

2. Hematopoietic stem cell transplantation for myelofibrosis: where are we now?;Fleischman;Curr Opin Hematol,2013

3. Use of the activating gene mutation (Val617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation;Steckel;Transplantation,2007

4. Impact of JAK2 V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis;Alchalby;Blood,2010

5. JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse;Lange;Haematologica,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory methods of monitoring disease response after allogeneic haematopoietic stem cell transplantation for myelofibrosis;Pathology;2024-02

2. A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a PD-1 inhibitor;International Journal of Hematology;2021-01-03

3. Genetic studies in the evaluation of myeloproliferative neoplasms;Seminars in Hematology;2019-01

4. Real-Time PCR and Droplet Digital PCR: two techniques for detection of theJAK2V617Fmutation in Philadelphia-negative chronic myeloproliferative neoplasms;International Journal of Laboratory Hematology;2015-07-20